BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18310651)

  • 1. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.
    Ojiako K; Shingala H; Schorr C; Gerber DR
    Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding in the upper part of the gastrointestinal tract due to stress ulcers.
    Carlson RW; Baker L; Andhavarapu S
    Am J Crit Care; 2008 Mar; 17(2):148-9. PubMed ID: 18310652
    [No Abstract]   [Full Text] [Related]  

  • 3. Famotidine versus pantoprazole.
    Lwin AA
    Am J Crit Care; 2008 Jul; 17(4):311-2; author reply 312. PubMed ID: 18593828
    [No Abstract]   [Full Text] [Related]  

  • 4. Skeptical that pantoprazole dose can prevent bleeding.
    Lin HJ; Tsai JJ
    Am J Crit Care; 2008 Sep; 17(5):404; author reply 404-5. PubMed ID: 18775994
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial.
    Wong GLH; Lau LHS; Ching JYL; Tse YK; Ling RHY; Wong VWS; Chiu PWY; Lau JYW; Chan FKL
    Gut; 2020 Apr; 69(4):652-657. PubMed ID: 31229990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Ng FH; Wong SY; Lam KF; Chu WM; Chan P; Ling YH; Kng C; Yuen WC; Lau YK; Kwan A; Wong BC
    Gastroenterology; 2010 Jan; 138(1):82-8. PubMed ID: 19837071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
    Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
    Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
    Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
    Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection.
    Jeong HK; Park CH; Jun CH; Lee GH; Kim HI; Kim HS; Choi SK; Rew JS
    J Korean Med Sci; 2007 Dec; 22(6):1055-9. PubMed ID: 18162722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of famotidine vs ranitidine in critically ill patients in mechanical ventilation].
    Vargas V; Castro J; del Solar F; Sanhueza H; Aguila R; Luppi M; Fernández D; Rojas M
    Rev Med Chil; 1993 Jul; 121(7):746-51. PubMed ID: 8296077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors].
    Garrido A; Iborra MI; Saperas E; de Sousa M;
    Med Clin (Barc); 2010 May; 134(13):577-82. PubMed ID: 20189198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
    N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of clinical outcomes between hospitalized patients with COVID-19 who received famotidine or pantoprazole.
    Wagner JJ; St Cyr N; Douen A; Fogel J; Trillo J
    JGH Open; 2023 Jul; 7(7):464-469. PubMed ID: 37496815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.